Photo from wikipedia
The bacillus Calmette–Guerin (BCG) vaccine could reduce the incidence of multiple sclerosis (MS) through immunomodulation. Previous studies, presenting some limitations, reported no association. We re‐examined this association in a large… Click to show full abstract
The bacillus Calmette–Guerin (BCG) vaccine could reduce the incidence of multiple sclerosis (MS) through immunomodulation. Previous studies, presenting some limitations, reported no association. We re‐examined this association in a large cohort focusing on relapsing–remitting MS (RRMS).
Keywords:
calmette guerin;
bacillus calmette;
multiple sclerosis
Journal Title: European Journal of Neurology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: European Journal of Neurology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!